New schizophrenia drug safety checked in teens for two years

NCT ID NCT03238326

Completed Disease control Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. Source: ClinicalTrials.gov ↗

Summary

This study aimed to understand the long-term safety and side effects of the medication brexpiprazole in teenagers (ages 13-17) with schizophrenia. Nearly 300 adolescents took a flexible dose of the drug for up to two years while researchers closely monitored their health. The main goal was to see how well the body tolerated the medication over a long period, not to test if it was a cure.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

Clinical Research Site #100

Rochester, New York, 14618, United States
Clinical Research Site #101

Dothan, Alabama, 36303, United States
Clinical Research Site #102

Oklahoma City, Oklahoma, 73116, United States
Clinical Research Site #103

Long Beach, California, 90807, United States
Clinical Research Site #105

Culver City, California, 90230, United States
Clinical Research Site #108

Everett, Washington, 98201, United States
Clinical Research Site #113

Garfield Heights, Ohio, 44125, United States
Clinical Research Site #121

Kinston, North Carolina, 28501, United States
Clinical Research Site #124

Las Vegas, Nevada, 89109, United States
Clinical Research Site #128

Anaheim, California, 92805, United States
Clinical Research Site #130

New York, New York, 10036, United States
Clinical Research Site #133

Cincinnati, Ohio, 45219, United States
Clinical Research Site #135

Tulsa, Oklahoma, 74136, United States
Clinical Research Site #136

Atlanta, Georgia, 30331, United States
Clinical Research Site #138

Lake Charles, Louisiana, 70629, United States
Clinical Research Site #140

Frisco, Texas, 75034, United States
Clinical Research Site #148

Kansas City, Kansas, 66160, United States
Clinical Research Site #160

Monterrey, Nuevo León, 64710, Mexico
Clinical Research Site #161

Culiacán, Sinaloa, 80230, Mexico
Clinical Research Site #163

León, Guanajuato, 37000, Mexico
Clinical Research Site #165

Guadalajara, Jalisco, 44100, Mexico
Clinical Research Site #166

Mérida, Yucatán, 97070, Mexico
Clinical Research Site #168

Durango, 34000, Mexico
Clinical Research Site #170

San Luis Potosí City, San Luis Potosí, 78213, Mexico
Clinical Research Site #171

Monterrey, Nuevo León, 64310, Mexico
Clinical Research Site #224

Torremolinos, Malaga, 29620, Spain
Clinical Research Site #241

Cluj-Napoca, 400660, Romania
Clinical Research Site #242

Timișoara, 300329, Romania
Clinical Research Site #243

Iași, IS700282, Romania
Clinical Research Site #244

Bucharest, 041914, Romania
Clinical Research Site #260

Poznan, 60-744, Poland
Clinical Research Site #263

Tyniec Mały, Dolnyslask, 55-040, Poland
Clinical Research Site #266

Bialystok, Podlaskie Voivodeship, 15-879, Poland
Clinical Research Site #267

Wroclaw, 54-617, Poland
Clinical Research Site #269

Gdansk, Polorskie, 80-542, Poland
Clinical Research Site #270

Wałbrzych, 58-309, Poland
Clinical Research Site #272

Poznan, 61-485, Poland
Clinical Research Site #283

Naples, 80131, Italy
Clinical Research Site #321

Nice, 06200, France
Clinical Research Site #500

Belgrade, 11000, Serbia
Clinical Research Site #501

Novi Sad, 21000, Serbia
Clinical Research Site #502

Niš, 18000, Serbia
Clinical Research Site #503

Kragujevac, 34000, Serbia
Clinical Research Site #504

Belgrade, 11000, Serbia
Clinical Research Site #520

Lviv, 79021, Ukraine
Clinical Research Site #521

Kharkiv, 61153, Ukraine
Clinical Research Site #522

Kherson, 73488, Ukraine
Clinical Research Site #523

Kharkiv, 61068, Ukraine
Clinical Research Site #525

Ternopil, 46027, Ukraine
Clinical Research Site #526

Poltava, Poltava Oblast, 36013, Ukraine
Clinical Research Site #527

Dnipro, 49027, Ukraine
Clinical Research Site #540

Saint Petersburg, 197341, Russia
Clinical Research Site #541

Saint Petersburg, 192019, Russia
Clinical Research Site #542

Arkhangelsk, Primorsky District, 163530, Russia
Clinical Research Site #543

Stavropol, Stavropolskiy Kray, 355038, Russia
Clinical Research Site #544

Yaroslavl, 150003, Russia
Clinical Research Site #545

Moscow, 127083, Russia

Conditions

Explore the condition pages connected to this study.

SCHIZOPHRENIA